Do analysts recommend NXGL or LUCY?

NexGel presently has a consensus price target of $2.00, indicating a potential upside of 652.45%. Given NexGel's higher probable upside, equities analysts clearly believe NexGel is more favorable than Innovative Eyewear. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score NexGel 1 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.50 Innovative Eyewear 1 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.50

Is NXGL or LUCY more profitable?

NexGel has a net margin of -51.26% compared to Innovative Eyewear's net margin of -225.26%. Innovative Eyewear's return on equity of -88.90% beat NexGel's return on equity. Company Net Margins Return on Equity Return on Assets NexGel -51.26% -121.18% -41.15% Innovative Eyewear -225.26% -88.90% -80.34%

Does the media refer more to NXGL or LUCY?

In the previous week, NexGel had 1 more articles in the media than Innovative Eyewear. MarketBeat recorded 2 mentions for NexGel and 1 mentions for Innovative Eyewear. NexGel's average media sentiment score of 0.46 beat Innovative Eyewear's score of 0.00 indicating that NexGel is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment NexGel 0 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Innovative Eyewear 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Which has stronger earnings & valuation, BMRA or NXGL?

NexGel has higher revenue and earnings than Biomerica. Biomerica is trading at a lower price-to-earnings ratio than NexGel, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Biomerica $4.45M 1.74 -$3.78M -$1.27 N/A NexGel $11.42M 0.23 -$3M -$0.71 N/A

Is BMRA or NXGL more profitable?

NexGel has a net margin of -51.26% compared to Biomerica's net margin of -84.79%. Biomerica's return on equity of -97.19% beat NexGel's return on equity. Company Net Margins Return on Equity Return on Assets Biomerica -84.79% -97.19% -61.57% NexGel -51.26% -121.18% -41.15%

Do analysts prefer CUPR or NXGL?

NexGel has a consensus price target of $2.00, suggesting a potential upside of 652.45%. Given NexGel's stronger consensus rating and higher probable upside, analysts clearly believe NexGel is more favorable than Cuprina Holdings (Cayman). Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Cuprina Holdings (Cayman) 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 NexGel 1 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.50

Which has higher valuation & earnings, CUPR or NXGL?

NexGel has higher revenue and earnings than Cuprina Holdings (Cayman). Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Cuprina Holdings (Cayman) $40K 41.17 -$3.63M N/A N/A NexGel $11.42M 0.23 -$3M -$0.71 N/A

Does the media refer more to CUPR or NXGL?

In the previous week, Cuprina Holdings (Cayman) had 3 more articles in the media than NexGel. MarketBeat recorded 5 mentions for Cuprina Holdings (Cayman) and 2 mentions for NexGel. NexGel's average media sentiment score of 0.46 beat Cuprina Holdings (Cayman)'s score of 0.22 indicating that NexGel is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Cuprina Holdings (Cayman) 0 Very Positive mention(s) 2 Positive mention(s) 2 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral NexGel 0 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Do analysts rate NXGL or LUCYW?

NexGel presently has a consensus target price of $2.00, suggesting a potential upside of 652.45%. Given NexGel's stronger consensus rating and higher probable upside, research analysts plainly believe NexGel is more favorable than Innovative Eyewear. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score NexGel 1 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.50 Innovative Eyewear 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00

Which has better earnings & valuation, NXGL or LUCYW?

Innovative Eyewear has lower revenue, but higher earnings than NexGel. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio NexGel $11.42M 0.23 -$3M -$0.71 N/A Innovative Eyewear $3.41M N/A N/A N/A N/A

Do analysts rate NXGLW or NXGL?

NexGel has a consensus price target of $2.00, indicating a potential upside of 652.45%. Given NexGel's stronger consensus rating and higher probable upside, analysts plainly believe NexGel is more favorable than NEXGEL. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score NEXGEL 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 NexGel 1 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.50

Which has preferable valuation and earnings, NXGLW or NXGL?

NEXGEL has higher revenue and earnings than NexGel. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio NEXGEL $12.07M N/A N/A N/A N/A NexGel $11.42M 0.23 -$3M -$0.71 N/A

Is NXGLW or NXGL more profitable?

NEXGEL has a net margin of 0.00% compared to NexGel's net margin of -51.26%. NEXGEL's return on equity of 0.00% beat NexGel's return on equity. Company Net Margins Return on Equity Return on Assets NEXGEL N/A N/A N/A NexGel -51.26% -121.18% -41.15%

Does the media favor NXGLW or NXGL?

In the previous week, NexGel had 1 more articles in the media than NEXGEL. MarketBeat recorded 2 mentions for NexGel and 1 mentions for NEXGEL. NexGel's average media sentiment score of 0.46 beat NEXGEL's score of 0.00 indicating that NexGel is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment NEXGEL 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral NexGel 0 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

NexGel (NXGL) Competitors

$0.27 +0.01 (+2.63%)

Closing price 09/18/2026 04:00 PM Eastern

Extended Trading

$0.28 +0.01 (+3.46%)

As of 09/18/2026 06:44 PM Eastern

Compare

NXGL vs. LUCY, BMRA, CUPR, LUCYW, and NXGLW

Should you buy NexGel stock or one of its competitors? NexGel's main competitors and comparable companies include Innovative Eyewear (LUCY), Biomerica (BMRA), Cuprina Holdings (Cayman) (CUPR), Innovative Eyewear (LUCYW), and NEXGEL (NXGLW). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare supplies" industry.

How does NexGel compare to Innovative Eyewear?

NexGel (NASDAQ:NXGL) and Innovative Eyewear (NASDAQ:LUCY) are both small-cap healthcare companies, but which is the better business? We will compare the two businesses based on the strength of their valuation, risk, profitability, institutional ownership, media sentiment, earnings, dividends and analyst recommendations.

NexGel has a beta of 0.76, suggesting that its stock price is 24% less volatile than the broader market. Comparatively, Innovative Eyewear has a beta of 2.76, suggesting that its stock price is 176% more volatile than the broader market.

NexGel presently has a consensus price target of $2.00, indicating a potential upside of 652.45%. Given NexGel's higher probable upside, equities analysts clearly believe NexGel is more favorable than Innovative Eyewear.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
NexGel	1 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.50
Innovative Eyewear	1 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.50

2.2% of NexGel shares are owned by institutional investors. Comparatively, 1.0% of Innovative Eyewear shares are owned by institutional investors. 19.8% of NexGel shares are owned by company insiders. Comparatively, 1.7% of Innovative Eyewear shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

NexGel has higher revenue and earnings than Innovative Eyewear. Innovative Eyewear is trading at a lower price-to-earnings ratio than NexGel, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
NexGel	$11.42M	0.23	-$3M	-$0.71	N/A
Innovative Eyewear	$2.66M	3.07	-$7.59M	-$1.29	N/A

In the previous week, NexGel had 1 more articles in the media than Innovative Eyewear. MarketBeat recorded 2 mentions for NexGel and 1 mentions for Innovative Eyewear. NexGel's average media sentiment score of 0.46 beat Innovative Eyewear's score of 0.00 indicating that NexGel is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
NexGel	0 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Innovative Eyewear	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

NexGel has a net margin of -51.26% compared to Innovative Eyewear's net margin of -225.26%. Innovative Eyewear's return on equity of -88.90% beat NexGel's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
NexGel	-51.26%	-121.18%	-41.15%
Innovative Eyewear	-225.26%	-88.90%	-80.34%

Summary

NexGel beats Innovative Eyewear on 11 of the 14 factors compared between the two stocks.

How does NexGel compare to Biomerica?

Biomerica (NASDAQ:BMRA) and NexGel (NASDAQ:NXGL) are both small-cap healthcare companies, but which is the better business? We will compare the two companies based on the strength of their institutional ownership, risk, earnings, profitability, analyst recommendations, dividends, valuation and media sentiment.

NexGel has higher revenue and earnings than Biomerica. Biomerica is trading at a lower price-to-earnings ratio than NexGel, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Biomerica	$4.45M	1.74	-$3.78M	-$1.27	N/A
NexGel	$11.42M	0.23	-$3M	-$0.71	N/A

22.3% of Biomerica shares are owned by institutional investors. Comparatively, 2.2% of NexGel shares are owned by institutional investors. 18.0% of Biomerica shares are owned by company insiders. Comparatively, 19.8% of NexGel shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

In the previous week, NexGel had 2 more articles in the media than Biomerica. MarketBeat recorded 2 mentions for NexGel and 0 mentions for Biomerica. NexGel's average media sentiment score of 0.46 beat Biomerica's score of 0.00 indicating that NexGel is being referred to more favorably in the news media.

Company	Overall Sentiment
Biomerica	Neutral
NexGel	Neutral

Biomerica has a beta of 0.37, suggesting that its stock price is 63% less volatile than the broader market. Comparatively, NexGel has a beta of 0.76, suggesting that its stock price is 24% less volatile than the broader market.

NexGel has a net margin of -51.26% compared to Biomerica's net margin of -84.79%. Biomerica's return on equity of -97.19% beat NexGel's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Biomerica	-84.79%	-97.19%	-61.57%
NexGel	-51.26%	-121.18%	-41.15%

Biomerica presently has a consensus target price of $9.00, suggesting a potential upside of 258.57%. NexGel has a consensus target price of $2.00, suggesting a potential upside of 652.45%. Given NexGel's stronger consensus rating and higher probable upside, analysts plainly believe NexGel is more favorable than Biomerica.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Biomerica	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
NexGel	1 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.50

Summary

NexGel beats Biomerica on 12 of the 15 factors compared between the two stocks.

How does NexGel compare to Cuprina Holdings (Cayman)?

Cuprina Holdings (Cayman) (NASDAQ:CUPR) and NexGel (NASDAQ:NXGL) are both small-cap healthcare companies, but which is the superior investment? We will contrast the two businesses based on the strength of their analyst recommendations, dividends, institutional ownership, profitability, media sentiment, risk, valuation and earnings.

NexGel has a consensus price target of $2.00, suggesting a potential upside of 652.45%. Given NexGel's stronger consensus rating and higher probable upside, analysts clearly believe NexGel is more favorable than Cuprina Holdings (Cayman).

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Cuprina Holdings (Cayman)	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
NexGel	1 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.50

2.2% of NexGel shares are owned by institutional investors. 19.8% of NexGel shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Cuprina Holdings (Cayman) has a beta of -0.37, suggesting that its stock price is 137% less volatile than the broader market. Comparatively, NexGel has a beta of 0.76, suggesting that its stock price is 24% less volatile than the broader market.

In the previous week, Cuprina Holdings (Cayman) had 3 more articles in the media than NexGel. MarketBeat recorded 5 mentions for Cuprina Holdings (Cayman) and 2 mentions for NexGel. NexGel's average media sentiment score of 0.46 beat Cuprina Holdings (Cayman)'s score of 0.22 indicating that NexGel is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Cuprina Holdings (Cayman)	0 Very Positive mention(s)	2 Positive mention(s)	2 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Neutral
NexGel	0 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Cuprina Holdings (Cayman) has a net margin of 0.00% compared to NexGel's net margin of -51.26%. Cuprina Holdings (Cayman)'s return on equity of 0.00% beat NexGel's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Cuprina Holdings (Cayman)	N/A	N/A	N/A
NexGel	-51.26%	-121.18%	-41.15%

NexGel has higher revenue and earnings than Cuprina Holdings (Cayman).

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Cuprina Holdings (Cayman)	$40K	41.17	-$3.63M	N/A	N/A
NexGel	$11.42M	0.23	-$3M	-$0.71	N/A

Summary

NexGel beats Cuprina Holdings (Cayman) on 8 of the 13 factors compared between the two stocks.

How does NexGel compare to Innovative Eyewear?

NexGel (NASDAQ:NXGL) and Innovative Eyewear (NASDAQ:LUCYW) are both healthcare companies, but which is the better stock? We will contrast the two companies based on the strength of their institutional ownership, dividends, analyst recommendations, profitability, valuation, risk, earnings and media sentiment.

2.2% of NexGel shares are owned by institutional investors. 19.8% of NexGel shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

In the previous week, NexGel had 2 more articles in the media than Innovative Eyewear. MarketBeat recorded 2 mentions for NexGel and 0 mentions for Innovative Eyewear. NexGel's average media sentiment score of 0.46 beat Innovative Eyewear's score of 0.00 indicating that NexGel is being referred to more favorably in the media.

Company	Overall Sentiment
NexGel	Neutral
Innovative Eyewear	Neutral

Innovative Eyewear has lower revenue, but higher earnings than NexGel.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
NexGel	$11.42M	0.23	-$3M	-$0.71	N/A
Innovative Eyewear	$3.41M	N/A	N/A	N/A	N/A

Innovative Eyewear has a net margin of 0.00% compared to NexGel's net margin of -51.26%. Innovative Eyewear's return on equity of 0.00% beat NexGel's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
NexGel	-51.26%	-121.18%	-41.15%
Innovative Eyewear	N/A	N/A	N/A

NexGel presently has a consensus target price of $2.00, suggesting a potential upside of 652.45%. Given NexGel's stronger consensus rating and higher probable upside, research analysts plainly believe NexGel is more favorable than Innovative Eyewear.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
NexGel	1 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.50
Innovative Eyewear	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00

Summary

NexGel beats Innovative Eyewear on 7 of the 10 factors compared between the two stocks.

How does NexGel compare to NEXGEL?

NEXGEL (NASDAQ:NXGLW) and NexGel (NASDAQ:NXGL) are both healthcare companies, but which is the better stock? We will contrast the two companies based on the strength of their media sentiment, institutional ownership, dividends, risk, analyst recommendations, profitability, valuation and earnings.

NEXGEL has higher revenue and earnings than NexGel.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
NEXGEL	$12.07M	N/A	N/A	N/A	N/A
NexGel	$11.42M	0.23	-$3M	-$0.71	N/A

2.2% of NexGel shares are owned by institutional investors. 19.8% of NexGel shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

NexGel has a consensus price target of $2.00, indicating a potential upside of 652.45%. Given NexGel's stronger consensus rating and higher probable upside, analysts plainly believe NexGel is more favorable than NEXGEL.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
NEXGEL	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00
NexGel	1 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.50

In the previous week, NexGel had 1 more articles in the media than NEXGEL. MarketBeat recorded 2 mentions for NexGel and 1 mentions for NEXGEL. NexGel's average media sentiment score of 0.46 beat NEXGEL's score of 0.00 indicating that NexGel is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
NEXGEL	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
NexGel	0 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

NEXGEL has a net margin of 0.00% compared to NexGel's net margin of -51.26%. NEXGEL's return on equity of 0.00% beat NexGel's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
NEXGEL	N/A	N/A	N/A
NexGel	-51.26%	-121.18%	-41.15%

Summary

NexGel beats NEXGEL on 6 of the 10 factors compared between the two stocks.

Get NexGel News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding NXGL and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

NXGL vs. The Competition

Export

Metric	NexGel	Healthcare Equipment & Supplies Industry	Healthcare Sector	NASDAQ Exchange
Market Cap	$2.59M	$5.55B	$7.24B	$13.19B
Dividend Yield	N/A	1.80%	2.57%	12.81%
P/E Ratio	-0.37	25.34	275.49	25.40
Price / Sales	0.23	72.49	646.01	89.45
Price / Cash	N/A	32.64	76.25	51.42
Price / Book	0.44	5.69	10.46	6.33
Net Income	-$3M	$151.55M	$3.49B	$358.33M
7 Day Performance	-8.69%	0.66%	0.59%	1.12%
1 Month Performance	-31.37%	-3.33%	-1.74%	-2.39%
1 Year Performance	-89.78%	6.79%	18.13%	5.35%

NexGel Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
NXGL NexGel	1.9188 of 5 stars	$0.27 +2.6%	$2.00 +652.4%	-89.8%	$2.59M	$11.42M	N/A	19
LUCY Innovative Eyewear	0.3514 of 5 stars	$0.87 +0.3%	N/A	-51.0%	$7.47M	$2.66M	N/A	9
BMRA Biomerica	2.0644 of 5 stars	$2.27 -3.0%	$9.00 +296.5%	-12.8%	$7.23M	$4.45M	N/A	60
CUPR Cuprina Holdings (Cayman)	0.9404 of 5 stars	$2.96 -5.1%	N/A	N/A	$2.87M	$40K	N/A	14	News Coverage
LUCYW Innovative Eyewear	N/A	$0.04 +0.3%	N/A	N/A	$0.00	$3.41M	N/A	9	Positive News

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:NXGL) was last updated on 9/20/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

NexGel (NXGL) Competitors

NXGL vs. LUCY, BMRA, CUPR, LUCYW, and NXGLW

How does NexGel compare to Innovative Eyewear?

Summary

How does NexGel compare to Biomerica?

Summary

How does NexGel compare to Cuprina Holdings (Cayman)?

Summary

How does NexGel compare to Innovative Eyewear?

Summary

How does NexGel compare to NEXGEL?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

NXGL vs. The Competition

NexGel Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

NexGel (NXGL) Competitors

NXGL vs. LUCY, BMRA, CUPR, LUCYW, and NXGLW

How does NexGel compare to Innovative Eyewear?

Which has more volatility & risk, NXGL or LUCY?

Do analysts recommend NXGL or LUCY?

Do institutionals and insiders believe in NXGL or LUCY?

Which has higher earnings and valuation, NXGL or LUCY?

Does the media refer more to NXGL or LUCY?

Is NXGL or LUCY more profitable?

Summary

How does NexGel compare to Biomerica?

Which has stronger earnings & valuation, BMRA or NXGL?

Do insiders & institutionals hold more shares of BMRA or NXGL?

Does the media prefer BMRA or NXGL?

Which has more volatility & risk, BMRA or NXGL?

Is BMRA or NXGL more profitable?

Do analysts rate BMRA or NXGL?

Summary

How does NexGel compare to Cuprina Holdings (Cayman)?

Do analysts prefer CUPR or NXGL?

Do institutionals & insiders have more ownership in CUPR or NXGL?

Which has more volatility & risk, CUPR or NXGL?

Does the media refer more to CUPR or NXGL?

Is CUPR or NXGL more profitable?

Which has higher valuation & earnings, CUPR or NXGL?

Summary

How does NexGel compare to Innovative Eyewear?

Do insiders and institutionals hold more shares of NXGL or LUCYW?

Does the media prefer NXGL or LUCYW?

Which has better earnings & valuation, NXGL or LUCYW?

Is NXGL or LUCYW more profitable?

Do analysts rate NXGL or LUCYW?

Summary

How does NexGel compare to NEXGEL?

Which has preferable valuation and earnings, NXGLW or NXGL?

Do institutionals and insiders believe in NXGLW or NXGL?

Do analysts rate NXGLW or NXGL?

Does the media favor NXGLW or NXGL?

Is NXGLW or NXGL more profitable?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

NXGL vs. The Competition

NexGel Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools